Literature DB >> 4864484

Age-related antinuclear factors: immunologic characteristics and associated clinical aspects.

K H Svec, B C Veit.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 4864484     DOI: 10.1002/art.1780100604

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  12 in total

1.  Correlation of smooth-muscle and nuclear antibodies in normal subjects.

Authors:  P Andersen
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

2.  Does prazosin induce formation of antinuclear factor?

Authors:  B O Kristensen
Journal:  Br Med J       Date:  1979-03-03

3.  Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  A Wiik; E Jensen; J Friis
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

4.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

5.  Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls.

Authors:  K Rhodes; A Scott; R L Markham; M E Monk-Jones
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

6.  Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

Authors:  D Alarcón-Segovia; E Fishbein; V M Betancourt
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

7.  [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].

Authors:  K Helmke; R Scheuermann; T Boeder; M Oppermann; J Teuber; K Federlin
Journal:  Klin Wochenschr       Date:  1981-03-16

8.  Speckled antinuclear factor in African sera.

Authors:  B M Greenwood; E M Herrick; E J Holborow
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

9.  The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis.

Authors:  S A Cairns; E J Acheson; C L Corbett; S Dosa; N P Mallick; W Lawler; G Williams
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

10.  Low-dose procainamide: low risk of complications with long-term use.

Authors:  C van Pham; J Noguchi; F P Quismorio; L J Haywood
Journal:  J Natl Med Assoc       Date:  1983-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.